Drug & supplement interaction

Myrcia + Ruxolitinib

Ruxolitinib brand names: Jakafi, Opzelura.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Myrcia and Ruxolitinib in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share
Interaction report

Myrcia and Ruxolitinib

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Ruxolitinib and Myrcia in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Myrcia safety at a glance

Myrcia overall Not established Human safety data are very limited, so caution is advised.
Pregnancy Avoid There is not enough safety information, so avoid use during pregnancy.
Breastfeeding Avoid Safety while breastfeeding is unknown, so it is best avoided.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Ruxolitinib and Myrcia? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for Ruxolitinib

Interactions in our licensed database are recorded against drug classes, not just single drug names. Ruxolitinib is filed under 3 classifications — topical drugs, cytochrome p450 3a4 (cyp3a4) substrates, oral drugs. Myrcia has documented interactions with 1 drug class — the most serious being levothyroxine (synthroid, others) (moderate) — and none of Ruxolitinib’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

Myrcia Does Interact With Other Medications

Myrcia has 3 moderate known drug interactions in our database — Ruxolitinib isn’t one of them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against Myrcia

Covers the 2,830 medications we’ve checked against Myrcia. Pick one to open its full report.

What to actually watch for

What Ruxolitinib’s Own FDA Label Lists

This is not an interaction — none of it involves Myrcia. These are the most notable effects listed in the ADVERSE REACTIONS section of Ruxolitinib’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 10 of them are worth acting on rather than waiting out — marked below.

  • Unsteadiness Worth acting on
  • Low blood sugar Worth acting on
  • Blood clots Worth acting on
  • Anemia Worth acting on mentioned in 8.6% of FDA reports for Ruxolitinib
  • A low platelet count Worth acting on mentioned in 3.9% of FDA reports for Ruxolitinib
  • A severe skin reaction Worth acting on
  • Raised blood pressure Worth acting on
  • Shortness of breath Worth acting on
  • A low white blood cell count Worth acting on
  • Bleeding or bruising Worth acting on

Showing the 10 most notable of 24 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Ruxolitinib. Read the label on DailyMed › Where a percentage is shown, it is the share of 69,262 voluntary FDA FAERS reports for Ruxolitinib that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Myrcia’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no Myrcia side to compare — that is a limit of the record, not a statement that Myrcia has no side effects.

Everything else you take

See Every Supplement That Interacts With Ruxolitinib

This page covers Myrcia only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Ruxolitinib page lists 141 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), Grapefruit (major), St. John's Wort (major), Acacia Rigidula (moderate) and Adrafinil (moderate).

By severity: 3 major · 96 moderate · 42 minor.

From our pharmacist’s overview on the Ruxolitinib page

“Ruxolitinib (Jakafi for myelofibrosis and other blood cancers, Opzelura as a skin cream) is cleared by one liver enzyme, CYP3A4, and that single fact explains nearly all 141 supplements here, which is why this list deserves real caution. Three entries are rated major.”

Reviewed by 2 · Jul 18, 2026

Open the Ruxolitinib interaction page

How much people look this up

Where Myrcia and Ruxolitinib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Myrcia
Steady interest

#1,367 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Ruxolitinib
Top 25%

#535 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Myrcia reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The Myrcia and Ruxolitinib records this page draws on were last updated June 22, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Myrcia

What is Myrcia?

  • Blood sugar support
  • Digestive upset and diarrhea
  • Mild urinary complaints
  • Astringent for the gut
  • Traditional 'pedra-hume-caa' folk remedy

Myrcia is a group of tropical shrubs and trees in the myrtle family, used in South American folk medicine—often as a tea—mainly for blood sugar and digestive complaints. Human evidence is very limited, so it should not replace proven treatments. Talk with your pharmacist or doctor before using it, especially if you have diabetes or take other medicines.

Myrtaceae · Leaves (and sometimes bark) · Tea, dried leaf, capsules, liquid extracts

An interaction check asks whether these two react with each other — it does not ask whether Myrcia is a good idea for someone in your situation. Here is what our Myrcia record says about it on its own.

Myrcia: dosing

There is no established standardized dose for Myrcia. Traditional use is usually as a tea made from the dried leaves, but amounts vary widely and are not backed by clinical research.If you choose to try a commercial product, follow the directions on the label and do not exceed them.

From our Myrcia monograph — the full record covers uses, side effects and every documented interaction.

Read the full Myrcia monograph & all interactions
Medication

About Ruxolitinib

What Is Ruxolitinib Used For?

Brand names: Jakafi, Opzelura

Ruxolitinib is approved to treat several serious blood and immune conditions in adults, and some in patients as young as 12. It is used for myelofibrosis (a bone marrow disorder that disrupts normal blood cell production), polycythemia vera (a condition where the bone marrow makes too many red blood cells), and two forms of graft-versus-host disease (GVHD) — a complication that can occur after a stem cell transplant.

For polycythemia vera, it is specifically for patients who have not responded well to, or cannot tolerate, a medication called hydroxyurea. For chronic GVHD, it is used after at least one or two other treatments have failed.

Most-Reported Side Effects for Ruxolitinib

From FAERS, the FDA’s public side-effect reporting system (71,241 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Fatigue 6,114 reports
Anemia 3,094 reports
Haemoglobin decreased 2,961 reports
Platelet count decreased 2,700 reports
Diarrhea 2,683 reports
See full Ruxolitinib drug information
Keep checking

Other Drugs & Myrcia

Browse every other medication we’ve checked against Myrcia — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
3Moderate
0Minor
2,826No known interaction
Moderate

3 interactions

No interaction 2,826 drugs checked — show the list
Evidence & sources

Myrcia References

The 2 references that drive our Myrcia monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Russo EM, Reichelt AA, De Sa JR, et al. Clinical trial of Myrcia uniflora and Bauhinia forficata leaf extracts in normal and diabetic patients. Braz J Med Biol Res 1990;23(1):11-20.
  2. Ferreira AC, Neto JC, da Silva AC, et al. Inhibition of thyroid peroxidase by Myrcia uniflora flavonoids. Chem Res Toxicol 2006;19(3):351-55.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Myrcia and Ruxolitinib Together: Common Questions

Is it safe to take Myrcia with Ruxolitinib?
We do not list a known interaction between Myrcia and Ruxolitinib. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
How was the Myrcia and Ruxolitinib combination checked?
Interactions in our licensed database are recorded against drug classes. Ruxolitinib is filed under 3 classifications, and Myrcia has documented interactions with 1 drug class — none of Ruxolitinib's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does Myrcia interact with any other medications?
Yes. Myrcia has 3 documented drug interactions in our database — Ruxolitinib is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Ruxolitinib interact with any supplements?
Yes. Ruxolitinib has documented interactions with 141 supplements in our database — Myrcia is not one of them. The Ruxolitinib interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Ruxolitinib and Myrcia?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.